Articles

The new facility also provides a plan for scalable product production processes that can potentially be replicated by Vaxxas domestically and globally.

Vaxxas Opens Manufacturing Facility for Clinical Trials and Commercial Products

Podcasts

Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy. 

Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

There is concern that debates will delay the five-year reauthorization of PEPFAR under review by Congress.

Long-Admired PEPFAR Program Caught in Abortion Debate

Advanco’s acquisition of Vantage Consulting Group boosts its position as a provider of independent pharmaceutical serialization solutions.

Advanco Acquires Vantage Consulting Group

The collaboration between the Pistoia Alliance and Matador Japan will work to accelerate research and promote access to a global pharmaceutical ecosystem.

Pistoia Alliance and Matador Japan Collaborate to Accelerate Research

The bioreactor scaler tool helps scaling between development and manufacturing and to de-risk scaling activities and ensure product quality.

Culture Biosciences and Cytiva to Collaborate on Innovative Upstream Bioprocessing 

The integration of the binders into a routine lateral flow test will support the clinical and commercial development of rapid diagnostics for Alzheimer’s disease through nasal sampling.

Aptamer Group and Neuro-Bio Collaborate to Develop Alzheimer’s Disease Diagnostic Test

Mendus and NorthX Biologics will work to develop and commercialize Mendus’ lead asset, vididencel, an allogeneic dendritic cell vaccine.

Mendus and NorthXBiologics Enter Cell Therapy Manufacturing Alliance

Charles River’s off-the-shelf lentiviral vector packaging plasmids are intended for use with cell and gene therapies.


Charles River Laboratories Launches LVV Packaging Plasmids

The investment, which is taking place in Hillerød, Denmark, will aim to create more production capacity and increase the company’s ability to meet future market demands and to continue development on its future clinical late-phase product portfolio.

News